Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Intersect Ent Inc (XENT)

Intersect Ent Inc (XENT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 954,907
  • Shares Outstanding, K 33,814
  • Annual Sales, $ 106,750 K
  • Annual Income, $ -159,640 K
  • 60-Month Beta 1.45
  • Price/Sales 8.95
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade XENT with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.67
  • Most Recent Earnings $-0.70 on 03/08/22
  • Next Earnings Date 05/16/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/22
See More
  • Average Estimate -0.34
  • Number of Estimates 1
  • High Estimate -0.34
  • Low Estimate -0.34
  • Prior Year -0.51
  • Growth Rate Est. (year over year) +33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.30 +3.44%
on 05/02/22
28.25 -0.04%
on 05/12/22
+0.31 (+1.11%)
since 04/12/22
3-Month
27.00 +4.59%
on 02/24/22
28.25 -0.04%
on 05/12/22
+0.91 (+3.33%)
since 02/11/22
52-Week
15.92 +77.39%
on 06/23/21
28.25 -0.04%
on 05/12/22
+10.62 (+60.27%)
since 05/12/21

Most Recent Stories

More News
Chart of the Day: Intersect Ent Inc. Surges to a 2-Year High

The Barchart Chart of the Day belongs to Intersect Ent Inc. (XENT) . I found the stock by using Barchart.com to find the "Barchart New Highs" page, and then I clicked on pull-down to select stocks with...

XENT : 28.24 (unch)
Real-World Evidence Study Demonstrates Intersect ENT’s PROPEL® Sinus Implant Reduces Healthcare Resource Utilization

Intersect ENT ® , Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced positive results of an observational,...

XENT : 28.24 (unch)
Orthofix Announces Appointment of Thomas A. West to Board of Directors

Orthofix Medical Inc . (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that Thomas A. West has been named to the Company’s Board of Directors and appointed...

OFIX : 13.52 (+1.73%)
XENT : 28.24 (unch)
Intersect ENT: Q3 Earnings Snapshot

MENLO PARK, Calif. (AP) _ Intersect ENT Inc. (XENT) on Tuesday reported a loss of $31.8 million in its third quarter.

XENT : 28.24 (unch)
Intersect ENT Reports Third Quarter 2021 Financial Results

Intersect ENT, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today reported financial results for the third quarter ended...

XENT : 28.24 (unch)
First Implants of PROPEL® Contour in Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery in Europe

Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that Helios Dr. Horst Schmidt Kliniken...

XENT : 28.24 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates XENT, INOV, SAFM, HOMB; Shareholders are Encouraged to Contact the Firm

NEW YORK, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

XENT : 28.24 (unch)
INOV : 28.62 (+0.50%)
SAFM : 204.00 (-2.51%)
HOMB : 23.72 (-1.41%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates SBKK, SAFM, LMRK, XENT; Shareholders are Encouraged to Contact the Firm

NEW YORK, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

SBKK : 18.5800 (+1.03%)
SAFM : 204.00 (-2.51%)
LMRK : 16.49 (+0.30%)
XENT : 28.24 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates INOV, LMRK, XENT, JAX; Shareholders are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / September 13, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Inovalon Holdings, Inc. (NASDAQ: INOV) concerning...

INOV : 28.62 (+0.50%)
LMRK : 16.49 (+0.30%)
XENT : 28.24 (unch)
JAX : 14.00 (+0.14%)
Lifshitz Law Firm, P.C. Announces Investigation of INOV, XENT, LMRK, and GTS

NEW YORK, Sept. 11, 2021 (GLOBE NEWSWIRE) --

INOV : 28.62 (+0.50%)
XENT : 28.24 (unch)
LMRK : 16.49 (+0.30%)
GTS : 35.99 (+1.04%)

Business Summary

Intersect ENT, Inc. is a commercial drug-device company. The Company's initial products, PROPEL and PROPEL mini, are drug-eluting implants for use in patients with chronic sinusitis. It offers products and therapies for ear, nose, and throat surgeons to improve treatment for their patients with chronic...

See More

Key Turning Points

3rd Resistance Point 28.27
2nd Resistance Point 28.26
1st Resistance Point 28.25
Last Price 28.24
1st Support Level 28.23
2nd Support Level 28.22
3rd Support Level 28.21

See More

52-Week High 28.25
Last Price 28.24
Fibonacci 61.8% 23.54
Fibonacci 50% 22.08
Fibonacci 38.2% 20.63
52-Week Low 15.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar